Cholesterol-lowering therapy: Is there really a controversy?

被引：7
作者：
Jungnickel, PW
机构：
[1] Department of Pharmacy Practice, University of Nebraska, Medical Center, Omaha, NE 68198
来源：
ANNALS OF PHARMACOTHERAPY | 1996年 / 30卷 / 05期
关键词：
D O I：
10.1177/106002809603000520
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：539 / 542
页数：4
相关论文
共 33 条
  • [1] THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION
    ANDERSON, TJ
    MEREDITH, IT
    YEUNG, AC
    FREI, B
    SELWYN, AP
    GANZ, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) : 488 - 493
  • [2] CHOLESTEROL REDUCTION AND THE RISK FOR STROKE IN MEN - A METAANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
    ATKINS, D
    PSATY, BM
    KOEPSELL, TD
    LONGSTRETH, WT
    LARSON, EB
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) : 136 - 145
  • [3] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .1. EFFICACY IN MODIFYING PLASMA-LIPOPROTEINS AND ADVERSE EVENT PROFILE IN 8245 PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA
    BRADFORD, RH
    SHEAR, CL
    CHREMOS, AN
    DUJOVNE, C
    DOWNTON, M
    FRANKLIN, FA
    GOULD, AL
    HESNEY, M
    HIGGINS, J
    HURLEY, DP
    LANGENDORFER, A
    NASH, DT
    POOL, JL
    SCHNAPER, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) : 43 - 49
  • [4] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B
    BROWN, G
    ALBERS, JJ
    FISHER, LD
    SCHAEFER, SM
    LIN, JT
    KAPLAN, C
    ZHAO, XQ
    BISSON, BD
    FITZPATRICK, VF
    DODGE, HT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) : 1289 - 1298
  • [5] REDUCTION IN CARDIOVASCULAR EVENTS DURING PRAVASTATIN THERAPY - POOLED ANALYSIS OF CLINICAL EVENTS OF THE PRAVASTATIN ATHEROSCLEROSIS INTERVENTION PROGRAM
    BYINGTON, RP
    JUKEMA, JW
    SALONEN, JT
    PITT, B
    BRUSCHKE, AV
    HOEN, H
    FURBERG, CD
    MANCINI, J
    [J]. CIRCULATION, 1995, 92 (09) : 2419 - 2425
  • [6] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN
    CANNER, PL
    BERGE, KG
    WENGER, NK
    STAMLER, J
    FRIEDMAN, L
    PRINEAS, RJ
    FRIEDEWALD, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255
  • [7] Does lowering cholesterol cause cancer?
    Dalen, JE
    Dalton, WS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (01): : 67 - 69
  • [8] ECKERNAS SA, 1993, BRIT J CLIN PHARMACO, V35, P284
  • [9] REDUCTION IN SERUM-CHOLESTEROL WITH PRAVASTATIN IMPROVES ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    EGASHIRA, K
    HIROOKA, Y
    KAI, H
    SUGIMACHI, M
    SUZUKI, S
    INOU, T
    TAKESHITA, A
    [J]. CIRCULATION, 1994, 89 (06) : 2519 - 2524
  • [10] EFFICACY OF GEMFIBROZIL IN DYSLIPIDEMIC SUBJECTS WITH SUSPECTED HEART-DISEASE - AN ANCILLARY STUDY IN THE HELSINKI HEART-STUDY FRAME POPULATION
    FRICK, MH
    HEINONEN, OP
    HUTTUNEN, JK
    KOSKINEN, P
    MANTTARI, M
    MANNINEN, V
    [J]. ANNALS OF MEDICINE, 1993, 25 (01) : 41 - 45
1234